Flupenthixol Decanoate in Methamphetamine Smoking - 1

Phase 2

Completed

• Conditions: Substance-Related Disorders

• Registration Number: NCT00000241
• Lead Sponsor: National Institute on Drug Abuse (NIDA)

Brief Summary

The purpose of this study is to evaluate the safety and efficacy of flupenthixol decanoate for treatment of methamphetamine dependence. Also, study will compare flupenthixol with desipramine in blocking methamphetamine self-administration.

Detailed Description

Not available

Study Timeline

• Study Start: 1994-02
• Study Completion: 1996-05
• Study First Submitted: 1999-09-20
• Study First Submitted QC: 1999-09-20
• Study First Posted: 1999-09-21
• Status Verified: 2016-10
• Last Update Submitted: 2017-01-11
• Last Update Posted: 2017-01-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 58

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Methamphetamine use

Trial Locations

Locations (1)

Friends Research Institute; 🇺🇸 Los Angeles, California, United States